[{"path":"/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"MIT License","title":"MIT License","text":"Copyright (c) 2023 ddir authors Permission hereby granted, free charge, person obtaining copy software associated documentation files (“Software”), deal Software without restriction, including without limitation rights use, copy, modify, merge, publish, distribute, sublicense, /sell copies Software, permit persons Software furnished , subject following conditions: copyright notice permission notice shall included copies substantial portions Software. SOFTWARE PROVIDED “”, WITHOUT WARRANTY KIND, EXPRESS IMPLIED, INCLUDING LIMITED WARRANTIES MERCHANTABILITY, FITNESS PARTICULAR PURPOSE NONINFRINGEMENT. EVENT SHALL AUTHORS COPYRIGHT HOLDERS LIABLE CLAIM, DAMAGES LIABILITY, WHETHER ACTION CONTRACT, TORT OTHERWISE, ARISING , CONNECTION SOFTWARE USE DEALINGS SOFTWARE.","code":""},{"path":"/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Rainer Strotmann. Maintainer.","code":""},{"path":"/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Strotmann R (2024). ddir: Assessment clinical DDI risk drug compounds. R package version 0.9.2.","code":"@Manual{,   title = {ddir: Assessment of the clinical DDI risk for drug compounds},   author = {Rainer Strotmann},   year = {2024},   note = {R package version 0.9.2}, }"},{"path":"/index.html","id":"ddir","dir":"","previous_headings":"","what":"Assessment of the clinical DDI risk for drug compounds","title":"Assessment of the clinical DDI risk for drug compounds","text":"package provides functions analysis clinical drug-drug interaction (DDI) risk per relevant FDA EMA guidelines.","code":""},{"path":"/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Assessment of the clinical DDI risk for drug compounds","text":"can install development version ddir using:","code":"devtools::install_github(\"rstrotmann/ddir\")"},{"path":"/index.html","id":"example","dir":"","previous_headings":"","what":"Example","title":"Assessment of the clinical DDI risk for drug compounds","text":"package provides sample data fictional drug, examplinib. following code calculates perpetrator DDI risk direct CYP inhibition (basic method) provides markdown-formatted output table: See also: kinetic_cyp_induction_risk_table(), mech_stat_cyp_risk_table(), basic_ugt_inhibition_risk_table(), transporter_inhibition_risk_table() Full documentation can found github.","code":"library(ddir)  p <- examplinib_compounds[[1]] property_table(p) basic_cyp_inhibition_risk_table(p, examplinib_cyp_inhibition_data)"},{"path":"/reference/basic_cyp_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"function evaluates clinical risk direct (reversible) CYP inhibition according basic model defined relevant regulatory guideines.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"","code":"basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"basic modeling direct (reversible) CYP enzyme inhibition, ratios relevant inhibitor concentration \\(K_i\\) considered, .e., \\(R_1\\) hepatic enzymes \\(R_{1,gut}\\) intestinal enzymes (refer fig. 1  FDA guidance). threshold 1.02 applies. Note section 5.3.3.1 EMA DDI guidance defines ratio \\(R_1=\\frac{I_{max,ss,u}}{K_{,u}}\\) threshold 0.02.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"liver","dir":"Reference","previous_headings":"","what":"Liver","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"$$R_1=1+\\frac{I_{max,ss,u}}{K_{,u}}$$","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"gut-wall","dir":"Reference","previous_headings":"","what":"Gut wall","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"$$R_{1,gut}=1+\\frac{I_{gut}}{K_{,u}}$$ Refer documentation key_concentrations() function details calculation \\(I_{max,ss,u}\\) \\(I_{gut}\\).","code":""},{"path":[]},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"","code":"basic_cyp_inhibition_risk(examplinib_parent, examplinib_cyp_inhibition_data) #>     param   ki  kiu    r1 risk_hep r1gut risk_intest #> 1  CYP1A2   NA   NA    NA       NA    NA          NA #> 2  CYP2B6   NA   NA    NA       NA    NA          NA #> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA #> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA #> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA #> 6  CYP2D6   NA   NA    NA       NA    NA          NA #> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE"},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"Basic CYP inhibition risk evaluation list perpetrator objects","code":""},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"","code":"# S3 method for list basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"perp Perpetrator objects list. cyp_inh CYP inhibition data data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"list data frames.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"","code":"basic_cyp_inhibition_risk(examplinib_compounds, examplinib_cyp_inhibition_data) #> $examplinib #>     param   ki  kiu    r1 risk_hep r1gut risk_intest #> 1  CYP1A2   NA   NA    NA       NA    NA          NA #> 2  CYP2B6   NA   NA    NA       NA    NA          NA #> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA #> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA #> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA #> 6  CYP2D6   NA   NA    NA       NA    NA          NA #> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE #>  #> $M1 #>    param  ki kiu    r1 risk_hep r1gut risk_intest #> 1 CYP2C9 4.4 4.4 1.006    FALSE    NA          NA #>"},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"Basic CYP inhibition risk evaluation perpetrator object","code":""},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"","code":"# S3 method for perpetrator basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"perp perpetrator object. cyp_inh CYP inhibiton data data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"","code":"basic_cyp_inhibition_risk(examplinib_parent, examplinib_cyp_inhibition_data) #>     param   ki  kiu    r1 risk_hep r1gut risk_intest #> 1  CYP1A2   NA   NA    NA       NA    NA          NA #> 2  CYP2B6   NA   NA    NA       NA    NA          NA #> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA #> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA #> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA #> 6  CYP2D6   NA   NA    NA       NA    NA          NA #> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE"},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"function generates markdown-formatted table direct (reversible) CYP inhibition risk assessment. See basic_cyp_inhibition_risk() details calculation risk.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"","code":"basic_cyp_inhibition_risk_table(perp, cyp_inh, na.rm = F)"},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. na.rm Boolean define whether rows lacking ki data removed (.e., ki == NA).","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"markdown-formatted table, empty string (CYP inhibition data vavailable).","code":""},{"path":[]},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP1A2  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2B6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2C8  |    11.0|      11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |    13.5|      13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |    15.0|      15.0|1.011 |FALSE          |NA          |NA                | #> |CYP2D6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP3A4  |    12.5|      12.5|1.013 |FALSE          |293.3       |TRUE              | basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data, na.rm = TRUE) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP2C8  |    11.0|      11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |    13.5|      13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |    15.0|      15.0|1.011 |FALSE          |NA          |NA                | #> |CYP3A4  |    12.5|      12.5|1.013 |FALSE          |293.3       |TRUE              |"},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"Table basic CYP inhibition risk","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"","code":"# S3 method for list basic_cyp_inhibition_risk_table(perp, cyp_inh, na.rm = F)"},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"perp list perpetrator objects. cyp_inh CYP inhibition data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"Basic evaluation CYP inhibition risk markdown-formatted tables, empty string CYP inhibition data available.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_compounds, examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP1A2  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2B6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2C8  |    11.0|      11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |    13.5|      13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |    15.0|      15.0|1.011 |FALSE          |NA          |NA                | #> |CYP2D6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP3A4  |    12.5|      12.5|1.013 |FALSE          |293.3       |TRUE              | #>  #>  #> Table: Risk for direct CYP inhibition by M1 (basic model) #>  #> |CYP    | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP2C9 |     4.4|       4.4|1.006 |FALSE          |NA          |NA                |"},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"Table basic CYP inhibition risk","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"","code":"# S3 method for perpetrator basic_cyp_inhibition_risk_table(perp, cyp_inh, na.rm = F)"},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"Basic evaluation CYP inhibition risk markdown-formatted table, empty string CYP inhibition data available.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP1A2  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2B6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2C8  |    11.0|      11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |    13.5|      13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |    15.0|      15.0|1.011 |FALSE          |NA          |NA                | #> |CYP2D6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP3A4  |    12.5|      12.5|1.013 |FALSE          |293.3       |TRUE              |"},{"path":"/reference/basic_ugt_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"UGT inhibition risk — basic_ugt_inhibition_risk","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"function evaluates clinical risk reversible inhibition UGT enzymes according relevant FDA EMA guidelines.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"","code":"basic_ugt_inhibition_risk(perp, ugt_inh)"},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, 'value' representing IC50 (!).","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"markdown-formatted table.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"function assumes UGT inhibition data provided \\(IC_{50}\\). According Cheng, Prusoff 1973), \\(K_i\\) can assumed \\(IC_{50}/2\\) experimental conditions commonly used vitro ihibition studies substrate concentrations close \\(K_M\\) used. relevant metric basic modeling UGT inhibition risk \\(R_1=I_{max,ss,u}/K_{,u}\\). clinical risk assessment, cut-\\(R<1.02\\) applies. Refer documentation key_concentrations() function details calculation \\(I_{max,ss,u}\\).","code":""},{"path":[]},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"function generates markdown-formatted table reversible UGT inhibition risk assessment. See basic_ugt_inhibition_risk() details calculation risk.","code":""},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"","code":"basic_ugt_inhibition_risk_table(perp, ugt_inh, na.rm = F)"},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, 'value' representing IC50 (!). na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/compound_names_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Compound names as single string — compound_names_string","title":"Compound names as single string — compound_names_string","text":"function returns single string comma-separated names compounds included list compunds.","code":""},{"path":"/reference/compound_names_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Compound names as single string — compound_names_string","text":"","code":"compound_names_string(compounds)"},{"path":"/reference/compound_names_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Compound names as single string — compound_names_string","text":"compounds list perpetrator objects","code":""},{"path":"/reference/compound_names_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Compound names as single string — compound_names_string","text":"character string.","code":""},{"path":"/reference/compound_names_string.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Compound names as single string — compound_names_string","text":"","code":"compound_names_string(examplinib_compounds) #> [1] \"examplinib and M1\""},{"path":"/reference/conc_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — conc_table","title":"Key perpetrator concentrations — conc_table","text":"Key perpetrator concentrations","code":""},{"path":"/reference/conc_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — conc_table","text":"","code":"conc_table(perp)"},{"path":"/reference/conc_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — conc_table","text":"perp object (compound object list thereof)","code":""},{"path":[]},{"path":"/reference/conc_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — conc_table","text":"","code":"conc_table(examplinib_parent) #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      |"},{"path":"/reference/conc_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of key perpetrator concentrations for a list of compounds — conc_table.list","title":"Table of key perpetrator concentrations for a list of compounds — conc_table.list","text":"function generates markdown-formatted table key concentrations used assessment DDI perpetrator potential. See key_concentrations() details calculation concentrations.","code":""},{"path":"/reference/conc_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of key perpetrator concentrations for a list of compounds — conc_table.list","text":"","code":"# S3 method for list conc_table(perp)"},{"path":"/reference/conc_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of key perpetrator concentrations for a list of compounds — conc_table.list","text":"perp compounds list compound objects.","code":""},{"path":"/reference/conc_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of key perpetrator concentrations for a list of compounds — conc_table.list","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/conc_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of key perpetrator concentrations for a list of compounds — conc_table.list","text":"","code":"conc_table(examplinib_compounds) #> $examplinib #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      | #>  #> $M1 #>  #>  #> Table: Key perpetrator concentrations for M1 #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |0.0           |0.0000     | #> |$I_{max,ss,u}$         |12.5          |0.0246     | #> |$I_{max,inlet,u}$      |12.5          |0.0246     | #> |$I_{max,intestinal,u}$ |12.5          |0.0246     | #>"},{"path":"/reference/conc_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — conc_table.perpetrator","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"function generates markdown-formatted table key concentrations used assessment DDI perpetrator potential. See key_concentrations() details calculation concentrations.","code":""},{"path":"/reference/conc_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"","code":"# S3 method for perpetrator conc_table(perp)"},{"path":"/reference/conc_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"perp perpetrator object.","code":""},{"path":"/reference/conc_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/conc_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"","code":"conc_table(examplinib_parent) #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      |"},{"path":"/reference/cyp_reference_substrates.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP reference substrate data — cyp_reference_substrates","title":"CYP reference substrate data — cyp_reference_substrates","text":"CYP reference substrates commonly used mechanistic static assessment CYP DDI perpetrator potential drugs.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP reference substrate data — cyp_reference_substrates","text":"","code":"cyp_reference_substrates"},{"path":"/reference/cyp_reference_substrates.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CYP reference substrate data — cyp_reference_substrates","text":"object class data.frame 5 rows 5 columns.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"CYP reference substrate data — cyp_reference_substrates","text":"FDA EMA guidelines.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP reference substrate data — cyp_reference_substrates","text":"CYP reference substrates currently implemented include:","code":"cyp   substrate fgut   fm fmcyp 1  CYP1A2  tizanidine 1.00 0.95  0.98 2  CYP2C8 repaglinide 1.00 1.00  0.61 3  CYP2C9  S-warfarin 1.00 1.00  0.91 4 CYP2C19  omeprazole 1.00 1.00  0.87 5  CYP3A4   midazolam 0.57 0.96  1.00"},{"path":[]},{"path":"/reference/ddir-package.html","id":null,"dir":"Reference","previous_headings":"","what":"ddir: Assessment of the clinical DDI risk for drug compounds — ddir-package","title":"ddir: Assessment of the clinical DDI risk for drug compounds — ddir-package","text":"goal ddir facilitate analysis drug-drug interaction risk drug compounds per relevant FDA EMA guidelines.","code":""},{"path":"/reference/df_to_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Render data frame to character. — df_to_string","title":"Render data frame to character. — df_to_string","text":"function renders data frame string object.","code":""},{"path":"/reference/df_to_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Render data frame to character. — df_to_string","text":"","code":"df_to_string(df, indent = \"\", n = NULL, colnames = TRUE)"},{"path":"/reference/df_to_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Render data frame to character. — df_to_string","text":"df datavframe. indent string defines left indentation rendered output. n number lines rendered. NULL (default), lines rendered. colnames Boolean value indicate whether column names included output.","code":""},{"path":"/reference/df_to_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Render data frame to character. — df_to_string","text":"data frame representation character.","code":""},{"path":"/reference/examplinib_compounds.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional substrate data — examplinib_compounds","title":"Fictional substrate data — examplinib_compounds","text":"list two: perpetrator objects: examplinib, fictional drug. M1, fictional metabolite examplinib.","code":""},{"path":"/reference/examplinib_compounds.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional substrate data — examplinib_compounds","text":"","code":"examplinib_compounds"},{"path":"/reference/examplinib_compounds.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional substrate data — examplinib_compounds","text":"object class list length 2.","code":""},{"path":"/reference/examplinib_compounds.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Fictional substrate data — examplinib_compounds","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional substrate data as string — examplinib_compounds_string","title":"Fictional substrate data as string — examplinib_compounds_string","text":"text string containing data two: perpetrator objects: examplinib, fictional drug. M1, fictional metabolite examplinib.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional substrate data as string — examplinib_compounds_string","text":"","code":"examplinib_compounds_string"},{"path":"/reference/examplinib_compounds_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional substrate data as string — examplinib_compounds_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Fictional substrate data as string — examplinib_compounds_string","text":"Fictional data, made demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_induction_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional CYP induction data — examplinib_cyp_induction_data","title":"Fictional CYP induction data — examplinib_cyp_induction_data","text":"Fictional CYP induction data","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional CYP induction data — examplinib_cyp_induction_data","text":"","code":"examplinib_cyp_induction_data"},{"path":"/reference/examplinib_cyp_induction_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional CYP induction data — examplinib_cyp_induction_data","text":"object class data.frame 14 rows 6 columns.","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Fictional CYP induction data — examplinib_cyp_induction_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional CYP inhibition data — examplinib_cyp_inhibition_data","title":"Fictional CYP inhibition data — examplinib_cyp_inhibition_data","text":"data frame typical input following functions:","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional CYP inhibition data — examplinib_cyp_inhibition_data","text":"","code":"examplinib_cyp_inhibition_data"},{"path":[]},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"examplinib-cyp-inhibition-data","dir":"Reference","previous_headings":"","what":"examplinib_cyp_inhibition_data","title":"Fictional CYP inhibition data — examplinib_cyp_inhibition_data","text":"data frame columns name, param, value source, : name name compound data recorded param contains respective CYP enzyme names. value contains Ki values respective CYP enzyme source provides information source respective value, often name DMPK study. entry optional.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Fictional CYP inhibition data — examplinib_cyp_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Fictional CYP inhibition data — examplinib_cyp_inhibition_data","text":"basic_cyp_inhibition_risk() basic_cyp_inhibition_risk_table mech_stat_cyp_risk() mech_stat_cyp_risk_table() CYP inhibition data can contain ki data multiple compounds.","code":""},{"path":"/reference/examplinib_metabolite.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional examplinib metabolite compound data — examplinib_metabolite","title":"Fictional examplinib metabolite compound data — examplinib_metabolite","text":"perpetrator object 'examplinib-M1'.","code":""},{"path":"/reference/examplinib_metabolite.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional examplinib metabolite compound data — examplinib_metabolite","text":"","code":"examplinib_metabolite"},{"path":"/reference/examplinib_metabolite.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional examplinib metabolite compound data — examplinib_metabolite","text":"object class perpetrator (inherits data.frame) 12 rows 3 columns.","code":""},{"path":"/reference/examplinib_metabolite.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Fictional examplinib metabolite compound data — examplinib_metabolite","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_parent.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional examplnib parent compound data — examplinib_parent","title":"Fictional examplnib parent compound data — examplinib_parent","text":"perpetrator object 'examplinib'.","code":""},{"path":"/reference/examplinib_parent.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional examplnib parent compound data — examplinib_parent","text":"","code":"examplinib_parent"},{"path":"/reference/examplinib_parent.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional examplnib parent compound data — examplinib_parent","text":"object class perpetrator (inherits data.frame) 13 rows 3 columns.","code":""},{"path":"/reference/examplinib_parent.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Fictional examplnib parent compound data — examplinib_parent","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional transporter inhibition data — examplinib_transporter_inhibition_data","title":"Fictional transporter inhibition data — examplinib_transporter_inhibition_data","text":"Fictional transporter inhibition data","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional transporter inhibition data — examplinib_transporter_inhibition_data","text":"","code":"examplinib_transporter_inhibition_data"},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional transporter inhibition data — examplinib_transporter_inhibition_data","text":"object class data.frame 12 rows 4 columns.","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Fictional UGT inhibition data — examplinib_ugt_inhibition_data","title":"Fictional UGT inhibition data — examplinib_ugt_inhibition_data","text":"Fictional UGT inhibition data","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fictional UGT inhibition data — examplinib_ugt_inhibition_data","text":"","code":"examplinib_ugt_inhibition_data"},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Fictional UGT inhibition data — examplinib_ugt_inhibition_data","text":"object class data.frame 18 rows 4 columns.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":null,"dir":"Reference","previous_headings":"","what":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"solubility field Inf (default), compound solubility larger Igut, function returns FALSE. solubility lower theoretical Igut, .e., lower dose dissolved 250 ml, function returns TRUE. Note solubility expected mg/l.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"","code":"is_igut_solubility_limited(obj)"},{"path":"/reference/is_igut_solubility_limited.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"obj perpetrator object.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"boolean value.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"","code":"is_igut_solubility_limited(examplinib_parent) #> [1] FALSE"},{"path":"/reference/key_concentrations.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — key_concentrations","title":"Key perpetrator concentrations — key_concentrations","text":"Key perpetrator concentrations","code":""},{"path":"/reference/key_concentrations.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — key_concentrations","text":"","code":"key_concentrations(obj, qh = 1.616, qent = 18/60, molar = TRUE)"},{"path":"/reference/key_concentrations.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — key_concentrations","text":"obj perpetrator object. qh Hepatic blood flow l/min, defaults 1.616 l/min. qent Enteric blood flow l/min, defaults 0.3 l/min = 18 l/h. molar Boolean value select output molar concentrations.","code":""},{"path":"/reference/key_concentrations.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Key perpetrator concentrations — key_concentrations","text":"Key perpetrator concentrations named vector.","code":""},{"path":[]},{"path":"/reference/key_concentrations.html","id":"gut-concentration","dir":"Reference","previous_headings":"","what":"Gut concentration","title":"Key perpetrator concentrations — key_concentrations","text":"$$I_{gut} = \\frac{D} {250}$$","code":""},{"path":"/reference/key_concentrations.html","id":"systemic-concentration","dir":"Reference","previous_headings":"","what":"Systemic concentration","title":"Key perpetrator concentrations — key_concentrations","text":"$$I_{max,ss,u}=I_{max,ss} * f_u$$","code":""},{"path":"/reference/key_concentrations.html","id":"hepatic-inlet-concentration","dir":"Reference","previous_headings":"","what":"Hepatic inlet concentration","title":"Key perpetrator concentrations — key_concentrations","text":"orally administered (parent) compounds, hepatic inlet concentration sytemic concentration plus portal term: $$portal\\ term = D*\\frac{F_a*F_g*k_a}{Q_h*R_B}*1000\\ ng/ml$$ \\(D\\) administered dose mg, \\(F_a\\) fraction absorbed oral administration, \\(F_g\\) fraction available gut metabolism, \\(k_a\\) absorption rate, \\(Q_h\\) hepatic blood flow \\(R_B\\) blood--plasma ratio. relevant hepatic inlet concentration (\\(I_{max,inlet,u}\\), also called \\(I_h\\) mechanistic static modeling equations) concentration sum maximal systemic plasma concentration portal contribution: $$I_{max,inlet,u}=(I_{max,ss} + portal\\ term) * f_u$$","code":""},{"path":"/reference/key_concentrations.html","id":"enteric-concentration","dir":"Reference","previous_headings":"","what":"Enteric concentration","title":"Key perpetrator concentrations — key_concentrations","text":"orally administered (parent) compounds, villous concentration gut (\\(I_{enteric}\\), also called \\(I_g\\) mechanistic static modeling equations) calculated : $$I_{enteric,u} = D * \\frac{F_a*k_a}{Q_{ent}} *1000\\ ng/ml$$ \\(F_a\\) fraction absorbed oral administration, \\(k_a\\) absorption rate, \\(Q_{ent}\\) enteric villous blood flow \\(R_B\\) blood--plasma distribution ratio compound. Note per FDA guideline (refer FDA, 2020, Fig. 7, Rostami-Hodjegan Tucker, 2004) blood--plasma ratio plasma binding drug ignored.","code":""},{"path":[]},{"path":"/reference/key_concentrations.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — key_concentrations","text":"","code":"key_concentrations(examplinib_parent) #>         igut      imaxssu   imaxinletu  imaxintestu  #> 3654.0803898    0.1648193    0.1929384    0.1514680  key_concentrations(examplinib_metabolite) #>        igut     imaxssu  imaxinletu imaxintestu  #>  0.00000000  0.02458939  0.02458939  0.02458939"},{"path":"/reference/kinetic_cyp_induction_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"","code":"kinetic_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"perp perpetrator object. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"Basic kinetic modeling CYP induction risk considers \\(R_3\\) (refer FDA 2020): $$R_3 = \\frac {1}{1+d* \\frac {E_{max}*10*I_{max,u}}{EC_{50} + 10*I_{max,u}}}$$ risk assessment, threshold 0.8 applies \\(R_3\\).","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"","code":"kinetic_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax ec50 maxc    source        r3 risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE"},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"","code":"# S3 method for list kinetic_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"perp list perpetrator objects. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"list data frames.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"","code":"kinetic_cyp_induction_risk(examplinib_compounds, examplinib_cyp_induction_data) #> $examplinib #>       cyp emax ec50 maxc    source        r3 risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE #>  #> $M1 #>       cyp  emax ec50 maxc    source        r3 risk #> 1  CYP1A2  1.00   NA    5 study 007        NA   NA #> 2  CYP2B6  6.98 1.86    5 study 007 0.5509590 TRUE #> 3  CYP2C8    NA   NA   NA                  NA   NA #> 4  CYP2C9    NA   NA   NA                  NA   NA #> 5 CYP2C19    NA   NA   NA                  NA   NA #> 6  CYP2D6    NA   NA   NA                  NA   NA #> 7  CYP3A4 22.70 1.10    5 study 007 0.1942776 TRUE #>"},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"","code":"# S3 method for perpetrator kinetic_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"perp perpetrator object. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"","code":"kinetic_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax ec50 maxc    source        r3 risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE"},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"Table basic kinetc CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"","code":"kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"perp perpetrator object. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"","code":"kinetic_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for CYP induction by examplinib (basic kinetic model) #>  #> |CYP     | $E_{max}$| $EC_{50}$| $max c$|source    |$R_3$ |risk | #> |:-------|---------:|---------:|-------:|:---------|:-----|:----| #> |CYP1A2  |      1.00|        NA|       5|study 007 |NA    |NA   | #> |CYP2B6  |      1.00|        NA|       5|study 007 |NA    |NA   | #> |CYP2C8  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2C9  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2C19 |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2D6  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP3A4  |      7.35|      1.64|       3|study 007 |0.213 |TRUE |"},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"Table basic kinetc CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"","code":"# S3 method for list kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"perp list perpetrator objects. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"markdown-formatted table.","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"Table basic kinetc CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"","code":"# S3 method for perpetrator kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"perp perpetrator object. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"","code":"kinetic_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for CYP induction by examplinib (basic kinetic model) #>  #> |CYP     | $E_{max}$| $EC_{50}$| $max c$|source    |$R_3$ |risk | #> |:-------|---------:|---------:|-------:|:---------|:-----|:----| #> |CYP1A2  |      1.00|        NA|       5|study 007 |NA    |NA   | #> |CYP2B6  |      1.00|        NA|       5|study 007 |NA    |NA   | #> |CYP2C8  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2C9  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2C19 |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2D6  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP3A4  |      7.35|      1.64|       3|study 007 |0.213 |TRUE |"},{"path":"/reference/make_perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Make perpetrator object — make_perpetrator","title":"Make perpetrator object — make_perpetrator","text":"function creates perpetrator object key compound data. Note 'source' field empty. want include source information, can either use new_perpetrator() takes input data may include source information, can create perpetrator object text input string using read_perpetrators().","code":""},{"path":"/reference/make_perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Make perpetrator object — make_perpetrator","text":"","code":"make_perpetrator(   name,   dose,   imaxss,   mw,   type = \"parent\",   oral = TRUE,   fu = 1,   fumic = 1,   rb = 1,   fa = 1,   fg = 1,   ka = 0.1,   solubility = Inf )"},{"path":"/reference/make_perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Make perpetrator object — make_perpetrator","text":"name compound name character. dose clinical dose mg. imaxss (total) steady-state Cmax ng/ml. mw molar weight g/mol. type compound type character. Must either 'parent' metabolite'. oral Oral administration Boolean. Defaults TRUE. fu fraction unbound numeric. Defaults 1. fumic fraction unbound microsomes. Defaults 1. rb blood--plasma concentration ratio. Defaults 1. fa fraction absorbed. Defaults 1. fg fraction escaping gut metabolism. Defaults 1. ka absorption rate constant /ml. Defaults 0.1 /ml. solubility aqueus solubility mg/l. Defaults Inf,","code":""},{"path":"/reference/make_perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Make perpetrator object — make_perpetrator","text":"perpetrator object.","code":""},{"path":[]},{"path":"/reference/make_perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Make perpetrator object — make_perpetrator","text":"","code":"make_perpetrator(\"test\", 100, 1000, 500) #> Deprecation warning: The input contains the field 'type'. This field was expected #> to have the values 'parent' or 'metabolite' to indicate whether the compound is #> subject to first-pass metabolism. This field has been deprecated. Please use instead #> 'oral' with the possible, values of 'TRUE' or 'FALSE'! #> For compatibility reasons, the field 'oral' bas been autogenerated and your input #> should still work. However, this function may be deleted in future releases. #> == DDI perpetrator object == #> name         test              #> oral         TRUE              #> mw           500               #> dose         100               #> imaxss       1000              #> fu           1                 #> fumic        1                 #> rb           1                 #> fa           1                 #> fg           1                 #> ka           0.1               #> solubility   Inf"},{"path":"/reference/mech_stat_cyp_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"CYP perpetration risk per mechanistic-static modeling","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"","code":"mech_stat_cyp_risk(   perp,   cyp_inh,   cyp_ind,   include_induction = T,   substr = cyp_reference_substrates )"},{"path":"/reference/mech_stat_cyp_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"perp perpetrator object. cyp_inh CYP inhibiton data data frame. cyp_ind CYP induction data data frame. include_induction Boolean value define whether induction included calculation (C-terms per FDA guideline) substr CYP reference substrates used data frame.","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"data frame.","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"approach, AUC ratios probe substrates calculated based known intestinal hepatic metabolism. direct (competitive) time-dependent inhibition considered. formula given FDA guideline (refer fig. 7 FDA 2020) also includes intestinal hepatic enzyme induction terms (\\(C_g\\) \\(C_h\\), respectively). time, guideline states inhibition induction considered separately. $$AUCR = \\frac{1}{A_g*B_g*C_g* \\left(1-F_g \\right)+F_g} * \\frac{1}{A_h*B_h*C_h*f_m+\\left(1-f_m\\right)}$$ individual terms :","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"reversible-inhibition","dir":"Reference","previous_headings":"","what":"Reversible inhibition","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$A_g = \\frac{1}{1+\\frac{I_g}{K_i}}$$ $$A_h = \\frac{1}{1+\\frac{I_h}{K_i}}$$","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"time-dependent-inhibition","dir":"Reference","previous_headings":"","what":"Time-dependent inhibition","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$B_g = \\frac{k_{deg,g}}{k_{deg,g} + \\frac{I_g*k_{inact}}{I_g+K_I}}$$ $$B_h = \\frac{k_{deg,h}}{k_{deg,h} + \\frac{I_h*k_{inact}}{I_h+K_I}}$$","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"induction","dir":"Reference","previous_headings":"","what":"Induction","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$C_g = 1 + \\frac{d*E_{max}*I_g}{I_g+EC_{50}}$$ $$C_h = 1 + \\frac{d*E_{max}*I_h}{I_h+EC_{50}}$$ hepatic inlet concentration \\(I_h=I_{max,inlet,u}\\) intestinal concentration \\(I_g=I_{enteric,u}\\), see key_concentrations(). \\(d\\) induction scaling factor (assumed 1, can adjusted).","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"","code":"mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data, examplinib_cyp_induction_data) #>       cyp   substrate  kiu fgut   fm fmcyp        Ag        Ah      Cg       Ch #> 1  CYP1A2  tizanidine   NA 1.00 0.95  0.98        NA        NA 1.00000 1.000000 #> 2  CYP2B6        <NA>   NA   NA   NA    NA        NA        NA 1.00000 1.000000 #> 3  CYP2C8 repaglinide 11.0 1.00 1.00  0.61 0.9864172 0.9827625 1.00000 1.000000 #> 4  CYP2C9  S-warfarin 13.5 1.00 1.00  0.91 0.9889046 0.9859096 1.00000 1.000000 #> 5 CYP2C19  omeprazole 15.0 1.00 1.00  0.87 0.9900031 0.9873008 1.00000 1.000000 #> 6  CYP2D6        <NA>   NA   NA   NA    NA        NA        NA 1.00000 1.000000 #> 7  CYP3A4   midazolam 12.5 0.57 0.96  1.00 0.9880276 0.9847995 1.62144 1.773674 #>        aucr  risk #> 1        NA    NA #> 2        NA    NA #> 3 1.0106266 FALSE #> 4 1.0129888 FALSE #> 5 1.0111717 FALSE #> 6        NA    NA #> 7 0.4626871  TRUE"},{"path":"/reference/mech_stat_cyp_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"CYP perpetration risk table per mechanistic-static modeling","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"","code":"mech_stat_cyp_risk_table(   perp,   cyp_inh,   cyp_ind,   include_induction = T,   substr = cyp_reference_substrates,   na.rm = FALSE )"},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"perp perpetrator object. cyp_inh CYP inhibiton data data frame. cyp_ind CYP induction data data frame. include_induction Boolean value define whether induction included calculation (C-terms per FDA guideline) substr CYP reference substrates used data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"","code":"mech_stat_cyp_risk_table(examplinib_parent,   examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data) #>  #>  #> Table: Mechanistic static modeling of CYP inhibition risk for  examplinib #>  #> |CYP     | $K_{i,u}$|substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$|$A_g$ |$A_h$ |$C_g$ |$C_h$ |AUCR  |risk  | #> |:-------|---------:|:-----------|---------:|-----:|-----------:|:-----|:-----|:-----|:-----|:-----|:-----| #> |CYP1A2  |        NA|tizanidine  |      1.00|  0.95|        0.98|NA    |NA    |1.00  |1.00  |NA    |NA    | #> |CYP2B6  |        NA|NA          |        NA|    NA|          NA|NA    |NA    |1.00  |1.00  |NA    |NA    | #> |CYP2C8  |      11.0|repaglinide |      1.00|  1.00|        0.61|0.986 |0.983 |1.00  |1.00  |1.011 |FALSE | #> |CYP2C9  |      13.5|S-warfarin  |      1.00|  1.00|        0.91|0.989 |0.986 |1.00  |1.00  |1.013 |FALSE | #> |CYP2C19 |      15.0|omeprazole  |      1.00|  1.00|        0.87|0.990 |0.987 |1.00  |1.00  |1.011 |FALSE | #> |CYP2D6  |        NA|NA          |        NA|    NA|          NA|NA    |NA    |1.00  |1.00  |NA    |NA    | #> |CYP3A4  |      12.5|midazolam   |      0.57|  0.96|        1.00|0.988 |0.985 |1.62  |1.77  |0.463 |TRUE  |"},{"path":"/reference/name.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic name method — name","title":"Generic name method — name","text":"Generic name method","code":""},{"path":"/reference/name.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic name method — name","text":"","code":"name(obj)"},{"path":"/reference/name.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic name method — name","text":"obj perpetrator object.","code":""},{"path":"/reference/name.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic name method — name","text":"name perpetrator character.","code":""},{"path":"/reference/name.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Name of a perpetrator — name.perpetrator","title":"Name of a perpetrator — name.perpetrator","text":"Name perpetrator","code":""},{"path":"/reference/name.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Name of a perpetrator — name.perpetrator","text":"","code":"# S3 method for perpetrator name(obj)"},{"path":"/reference/name.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Name of a perpetrator — name.perpetrator","text":"obj perpetrator object.","code":""},{"path":"/reference/name.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Name of a perpetrator — name.perpetrator","text":"name perpetrator character.","code":""},{"path":"/reference/name.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Name of a perpetrator — name.perpetrator","text":"","code":"name(examplinib_parent) #> [1] \"examplinib\""},{"path":[]},{"path":"/reference/names_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator names as comma-separated string — names_string","text":"","code":"names_string(perps)"},{"path":"/reference/names_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator names as comma-separated string — names_string","text":"perps perpetrator objects list.","code":""},{"path":"/reference/names_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator names as comma-separated string — names_string","text":"output string.","code":""},{"path":"/reference/new_perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator object constructor — new_perpetrator","title":"Perpetrator object constructor — new_perpetrator","text":"Perpetrator object constructor","code":""},{"path":"/reference/new_perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator object constructor — new_perpetrator","text":"","code":"new_perpetrator(df)"},{"path":"/reference/new_perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator object constructor — new_perpetrator","text":"df data frame converted perpetrator object. See 'Details' expected format fields.","code":""},{"path":"/reference/new_perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator object constructor — new_perpetrator","text":"perpetrator object.","code":""},{"path":"/reference/new_perpetrator.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator object constructor — new_perpetrator","text":"input data frame columns 'param', 'value' source'. Rows following parameters ('param') expected input: following example example valid input data frame:","code":"param      value        source 1        name examplinib 2        type     parent 3          mw      492.6 4        dose        450 clinical dose 5      imaxss       3530     study 001 6          fu      0.023     study 002 7       fumic          1       default 8          rb          1     study 003 9          fa       0.81     study 003 10         fg          1       default 11         ka    0.00267       unknown 12 solubility        Inf       default"},{"path":[]},{"path":"/reference/print.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Implementation of the generic print function for perpetrator objects — print.perpetrator","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"Implementation generic print function perpetrator objects","code":""},{"path":"/reference/print.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"","code":"# S3 method for perpetrator print(x, ...)"},{"path":"/reference/print.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"x perpetrator object. ... parameters.","code":""},{"path":"/reference/print.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"","code":"print(examplinib_parent) #> == DDI perpetrator object == #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> type         parent       default          #> solubility   Inf          default"},{"path":"/reference/property_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic function to display compound properties — property_table","title":"Generic function to display compound properties — property_table","text":"Generic function display compound properties","code":""},{"path":"/reference/property_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic function to display compound properties — property_table","text":"","code":"property_table(obj)"},{"path":"/reference/property_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic function to display compound properties — property_table","text":"obj object (compund object list thereof)","code":""},{"path":"/reference/property_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator drug properties for a list of compounds — property_table.list","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"function generates list markdown-formatted table key properties list perpetrator objects.","code":""},{"path":"/reference/property_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"","code":"# S3 method for list property_table(obj)"},{"path":"/reference/property_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"obj list perpetrator objects.","code":""},{"path":"/reference/property_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"list markdown-formatted tables.","code":""},{"path":"/reference/property_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"","code":"property_table(examplinib_compounds) #>  #>  #> Table: Compound parameters for examplinib #>  #> |parameter            |value   |source        | #> |:--------------------|:-------|:-------------| #> |$MW$ (g/mol)         |492.6   |              | #> |$dose$ (mg)          |450     |clinical dose | #> |$C_{max,ss}$ (ng/ml) |3530    |study 001     | #> |$f_u$                |0.023   |study 002     | #> |$f_{u,mic}$          |1       |default       | #> |$R_B$                |1       |study 003     | #> |$F_a$                |0.81    |study 003     | #> |$F_g$                |1       |default       | #> |$k_a$ (1/min)        |0.00267 |unknown       | #> |$solubility$ (mg/l)  |Inf     |default       | #>  #>  #> Table: Compound parameters for M1 #>  #> |parameter            |value  |source    | #> |:--------------------|:------|:---------| #> |$MW$ (g/mol)         |506.56 |          | #> |$dose$ (mg)          |NA     |          | #> |$C_{max,ss}$ (ng/ml) |1038   |study 001 | #> |$f_u$                |0.012  |study 002 | #> |$f_{u,mic}$          |1      |default   | #> |$R_B$                |1      |study 002 | #> |$solubility$ (mg/l)  |Inf    |default   |"},{"path":"/reference/property_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of perpetrator drug properties — property_table.perpetrator","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"function generates markdown-formatted table key properties perpetrator object.","code":""},{"path":"/reference/property_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"","code":"# S3 method for perpetrator property_table(obj)"},{"path":"/reference/property_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"obj perpetrator object.","code":""},{"path":"/reference/property_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":"/reference/property_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"","code":"property_table(examplinib_parent) #>  #>  #> Table: Compound parameters for examplinib #>  #> |parameter            |value   |source        | #> |:--------------------|:-------|:-------------| #> |$MW$ (g/mol)         |492.6   |              | #> |$dose$ (mg)          |450     |clinical dose | #> |$C_{max,ss}$ (ng/ml) |3530    |study 001     | #> |$f_u$                |0.023   |study 002     | #> |$f_{u,mic}$          |1       |default       | #> |$R_B$                |1       |study 003     | #> |$F_a$                |0.81    |study 003     | #> |$F_g$                |1       |default       | #> |$k_a$ (1/min)        |0.00267 |unknown       | #> |NA                   |parent  |default       | #> |$solubility$ (mg/l)  |Inf     |default       | property_table(examplinib_metabolite) #>  #>  #> Table: Compound parameters for M1 #>  #> |parameter            |value  |source    | #> |:--------------------|:------|:---------| #> |$MW$ (g/mol)         |506.56 |          | #> |$dose$ (mg)          |NA     |          | #> |$C_{max,ss}$ (ng/ml) |1038   |study 001 | #> |$f_u$                |0.012  |study 002 | #> |$f_{u,mic}$          |1      |default   | #> |$R_B$                |1      |study 002 | #> |$solubility$ (mg/l)  |Inf    |default   |"},{"path":"/reference/read_inducer_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP inducer data — read_inducer_data","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"function loads CYP inducer data csv file. expected fields (order) compound name, CYP enzyme, Emax, EC50, maximal tested concentration source reference. latter field may remain empty.","code":""},{"path":"/reference/read_inducer_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"","code":"read_inducer_data(source)"},{"path":"/reference/read_inducer_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"source connection read .","code":""},{"path":"/reference/read_inducer_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"data data frame.","code":""},{"path":"/reference/read_inducer_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"Comment lines must start '#'. valid source , e.g.,","code":"# PARENT # compound, CYP, Emax, EC50, max c, source examplinib, CYP1A2,  1,    NA,   5,  study 007 examplinib, CYP2B6,  1,    NA,   5,  study 007 examplinib, CYP2C8,  NA,   NA,   NA, examplinib, CYP2C9,  NA,   NA,   NA, examplinib, CYP2C19, NA,   NA,   NA, examplinib, CYP2D6,  NA,   NA,   NA, examplinib, CYP3A4,   7.35, 1.64, 3,  study 007  # METABOLITE # compound, CYP, ki, source M1, CYP1A2,  1,    NA,   5,  study 007 M1, CYP2B6,  6.98, 1.86, 5,  study 007 M1, CYP2C8,  NA,   NA,   NA, M1, CYP2C9,  NA,   NA,   NA, M1, CYP2C19, NA,   NA,   NA, M1, CYP2D6,  NA,   NA,   NA, M1, CYP3A4,  22.7, 1.1,  5,  study 007"},{"path":"/reference/read_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP inhibition data — read_inhibitor_data","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"function loads CYP inhibition data csv file. expected fields (order) compound name, CYP enzyme, Ki source information respective data. latter field may remain empty.","code":""},{"path":"/reference/read_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"","code":"read_inhibitor_data(source)"},{"path":"/reference/read_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"source connection read .","code":""},{"path":"/reference/read_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"data data frame.","code":""},{"path":"/reference/read_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"Comment lines must start '#'. valid source , e.g.,","code":"# PARENT # name,     CYP,     Ki,   source examplinib, CYP1A2,  NA, examplinib, CYP2B6,  NA, examplinib, CYP2C8,  11,   study 001 examplinib, CYP2C9,  13.5, study 001 examplinib, CYP2C19, 15,   study 001 examplinib, CYP2D6,  NA, examplinib, CYP3A4,  12.5, study 001 # METABOLITE # name,     CYP,     Ki,   source M1,         CYP2C9,  4.4,  study 002"},{"path":"/reference/read_perpetrators.html","id":null,"dir":"Reference","previous_headings":"","what":"Read perpetrator information from file or text string — read_perpetrators","title":"Read perpetrator information from file or text string — read_perpetrators","text":"input source can either file name string text connection. can used read compound data string.","code":""},{"path":"/reference/read_perpetrators.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read perpetrator information from file or text string — read_perpetrators","text":"","code":"read_perpetrators(source)"},{"path":"/reference/read_perpetrators.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read perpetrator information from file or text string — read_perpetrators","text":"source connection read .","code":""},{"path":"/reference/read_perpetrators.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read perpetrator information from file or text string — read_perpetrators","text":"list perpetrator objects.","code":""},{"path":"/reference/read_perpetrators.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read perpetrator information from file or text string — read_perpetrators","text":"file expected comply following: Comments start '#' go end line lines format: drug, parameter, value, source fields within line comma-separated fields plain text without enclosing \"\" source field reference usually refers clinical non-clinical study report. source field may remain empty. Note line ends comma. metabolites, fields dose, fa, fg ka relevant filled NA. metabolites, 'oral' must 'FALSE'. Note multiple compounds, e.g., parent metabolites may included perpetrator file. typical compound file look e.g., like :","code":"# name, param, value, source   # parent    examplinib,  oral,     TRUE,   examplinib,  mw,       492.6,   examplinib,  dose,     450,       clinical dose   examplinib,  imaxss,   3530,      study 001   examplinib,  fu,       0.023,     study 002   examplinib,  fumic,    1,         default   examplinib,  rb,       1,         study 003   examplinib,  fa,       0.81,      study 003   examplinib,  fg,       1,         default   examplinib,  ka,       0.00267,   unknown    # metabolite    M1,  oral,   FALSE,   M1,  mw,     506.56,   M1,  dose,   NA,   M1,  imaxss, 1038,      study 001   M1,  fu,     0.012,     study 002   M1,  fumic,  1,         default   M1,  rb,     1,         study 002   M1,  fa,     NA,   M1,  fg,     NA,   M1,  ka,     NA,"},{"path":"/reference/read_perpetrators.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read perpetrator information from file or text string — read_perpetrators","text":"","code":"read_perpetrators(textConnection(examplinib_compounds_string)) #> $M1 #> == DDI perpetrator object == #> name         M1                    #> oral         FALSE                 #> mw           506.56                #> dose         NA                    #> imaxss       1038     study 001    #> fu           0.012    study 002    #> fumic        1        default      #> rb           1        study 002    #> fa           NA                    #> fg           NA                    #> ka           NA                    #> solubility   Inf      default #> $examplinib #> == DDI perpetrator object == #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> solubility   Inf          default"},{"path":"/reference/static_cyp_induction_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"","code":"static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"basic (EMA) fold-change (FDA) methods evaluate whether maximal fold-change mRNA expression > 2-fold expected unbound hepatic concentration drug. Regarding relevant drug concentrations, FDA guidance suggests considering \\(30*I_{max,ss,u}\\) EMA guidance considers \\(50*I_{max,ss,u}\\) hepatic \\(0.1*I_{gut}\\) intestinal CYP enzyme induction. expected concentrations respective vitro assays cover concentrations.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"","code":"static_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax maxc    source maxc_imaxssu  risk #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE #> 3  CYP2C8   NA   NA                     NA    NA #> 4  CYP2C9   NA   NA                     NA    NA #> 5 CYP2C19   NA   NA                     NA    NA #> 6  CYP2D6   NA   NA                     NA    NA #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE #>                                                         note #> 1     Maximal tested concentration is below FDA expectations #> 2     Maximal tested concentration is below FDA expectations #> 3                                                            #> 4                                                            #> 5                                                            #> 6                                                            #> 7 Maximal tested concentration is below EMA/FDA expectations"},{"path":"/reference/static_cyp_induction_risk.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk.list","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"","code":"# S3 method for list static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"","code":"static_cyp_induction_risk(examplinib_compounds, examplinib_cyp_induction_data) #> $examplinib #>       cyp emax maxc    source maxc_imaxssu  risk #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE #> 3  CYP2C8   NA   NA                     NA    NA #> 4  CYP2C9   NA   NA                     NA    NA #> 5 CYP2C19   NA   NA                     NA    NA #> 6  CYP2D6   NA   NA                     NA    NA #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE #>                                                         note #> 1     Maximal tested concentration is below FDA expectations #> 2     Maximal tested concentration is below FDA expectations #> 3                                                            #> 4                                                            #> 5                                                            #> 6                                                            #> 7 Maximal tested concentration is below EMA/FDA expectations #>  #> $M1 #>       cyp  emax maxc    source maxc_imaxssu  risk note #> 1  CYP1A2  1.00    5 study 007        203.3 FALSE      #> 2  CYP2B6  6.98    5 study 007        203.3  TRUE      #> 3  CYP2C8    NA   NA                     NA    NA      #> 4  CYP2C9    NA   NA                     NA    NA      #> 5 CYP2C19    NA   NA                     NA    NA      #> 6  CYP2D6    NA   NA                     NA    NA      #> 7  CYP3A4 22.70    5 study 007        203.3  TRUE      #>"},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"","code":"# S3 method for perpetrator static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"","code":"static_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax maxc    source maxc_imaxssu  risk #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE #> 3  CYP2C8   NA   NA                     NA    NA #> 4  CYP2C9   NA   NA                     NA    NA #> 5 CYP2C19   NA   NA                     NA    NA #> 6  CYP2D6   NA   NA                     NA    NA #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE #>                                                         note #> 1     Maximal tested concentration is below FDA expectations #> 2     Maximal tested concentration is below FDA expectations #> 3                                                            #> 4                                                            #> 5                                                            #> 6                                                            #> 7 Maximal tested concentration is below EMA/FDA expectations"},{"path":"/reference/static_cyp_induction_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"Table basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"","code":"static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/static_cyp_induction_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"perp perpetrator object. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/static_cyp_induction_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/static_cyp_induction_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"","code":"static_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes                                                      | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:----------------------------------------------------------| #> |CYP1A2  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2B6  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP3A4  |      7.35|       3|study 007 |                 18.2|TRUE  |Maximal tested concentration is below EMA/FDA expectations |"},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"Tables basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"","code":"# S3 method for list static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"perp list perpetrator objects. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"list markdown-formatted tables.","code":""},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"","code":"static_cyp_induction_risk_table(examplinib_compounds, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes                                                      | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:----------------------------------------------------------| #> |CYP1A2  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2B6  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP3A4  |      7.35|       3|study 007 |                 18.2|TRUE  |Maximal tested concentration is below EMA/FDA expectations | #>  #>  #> Table: Risk for hepatic CYP induction by M1 (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:-----| #> |CYP1A2  |      1.00|       5|study 007 |                203.3|FALSE |      | #> |CYP2B6  |      6.98|       5|study 007 |                203.3|TRUE  |      | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |      | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |      | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |      | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |      | #> |CYP3A4  |     22.70|       5|study 007 |                203.3|TRUE  |      |"},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"Table basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"","code":"# S3 method for perpetrator static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"perp perpetrator object. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"","code":"static_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes                                                      | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:----------------------------------------------------------| #> |CYP1A2  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2B6  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP3A4  |      7.35|       3|study 007 |                 18.2|TRUE  |Maximal tested concentration is below EMA/FDA expectations |"},{"path":"/reference/transporter_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Drug transporter inhibition risk — transporter_inhibition_risk","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"Drug transporter inhibition risk","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"","code":"transporter_inhibition_risk(   perp,   transporter_ic50,   transporter_ref = transporter_reference_data )"},{"path":"/reference/transporter_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"perp perpetrator object. transporter_ic50 Transporter inhibition IC50 data frame. transporter_ref Transporter reference data.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"data frame.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"relevant metric assessment transporter interactions \\(R=[]/K_i\\). vitro transporter inhibition studies, \\(IC_{50}\\) values experimentally determined. Since transporter substrate concentration usually kept low relation \\(K_m\\) minimize passive permeation, \\(K_i = IC_{50}\\) can assumed. relevant perpetrator concentrations \\([]\\) : \\(I_{gut}\\) intestinal P-gp BRCR \\(I_{max,inlet,u}\\) hepatic basolateral transporters OCT1, OATP1B1 OATP1B3 \\(I_{max,ss,u}\\) renal basolateral transporters OAT1, OAT3 OCT2, well apical transporters outside intestinal mucosa, .e., hepatic P-gp BCRP, MATE1, MATE2-k. Note FDA EMA guidelines differ definitions thresholds assumed clinically relevant effects.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"","code":"transporter_inhibition_risk(examplinib_parent, examplinib_transporter_inhibition_data) #>       param   ic50    source            r fda_thld fda_risk ema_thld ema_risk #> 1   Pgp_int   0.41 study 005 8.912391e+03     10.0     TRUE    10.00     TRUE #> 2   Pgp_sys   0.41 study 005 4.019984e-01      0.1     TRUE     0.02     TRUE #> 3  BCRP_int   1.90 study 005 1.923200e+03     10.0     TRUE    10.00     TRUE #> 4  BCRP_sys   1.90 study 005 8.674701e-02      0.1    FALSE     0.02     TRUE #> 5      OCT1   2.30 study 006 8.388626e-02       NA       NA     0.04     TRUE #> 6   OATP1B1 177.00 study 006 1.090047e-03      0.1    FALSE     0.04    FALSE #> 7   OATP1B3  35.00 study 006 5.512525e-03      0.1    FALSE     0.04    FALSE #> 8      OAT1 271.00           6.081894e-04      0.1    FALSE     0.04    FALSE #> 9      OAT3 300.00           5.493978e-04      0.1    FALSE     0.04    FALSE #> 10     BSEP  12.80           1.287651e-02      0.1    FALSE     0.02    FALSE #> 11     OCT2  67.00 study 006 2.459990e-03      0.1    FALSE     0.02    FALSE #> 12    MATE1   3.60 study 006 4.578315e-02      0.1    FALSE     0.02     TRUE #> 13   MATE2k   1.10 study 006 1.498358e-01      0.1     TRUE     0.02     TRUE"},{"path":"/reference/transporter_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"Table drug transporter inhibition risks","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"","code":"transporter_inhibition_risk_table(   perp,   transporter_ic50,   transporter_ref = transporter_reference_data,   na.rm = F )"},{"path":"/reference/transporter_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"perp perpetrator object. transporter_ic50 Transporter inhibition IC50 data frame. transporter_ref Transporter reference data. na.rm Boolean indicate whether rows lacking ki data removed output (.e., ki == NA).","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/transporter_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"","code":"transporter_inhibition_risk_table(examplinib_parent, examplinib_transporter_inhibition_data) #>  #>  #> Table: Risk for drug transporter inhibition by examplinib #>  #> |transporter | $IC_{50}$|source    |      $R$| thld FDA|risk FDA | thld EMA|risk EMA | #> |:-----------|---------:|:---------|--------:|--------:|:--------|--------:|:--------| #> |Pgp_int     |      0.41|study 005 | 8912.391|     10.0|TRUE     |    10.00|TRUE     | #> |Pgp_sys     |      0.41|study 005 |    0.402|      0.1|TRUE     |     0.02|TRUE     | #> |BCRP_int    |      1.90|study 005 | 1923.200|     10.0|TRUE     |    10.00|TRUE     | #> |BCRP_sys    |      1.90|study 005 |    0.087|      0.1|FALSE    |     0.02|TRUE     | #> |OCT1        |      2.30|study 006 |    0.084|       NA|NA       |     0.04|TRUE     | #> |OATP1B1     |    177.00|study 006 |    0.001|      0.1|FALSE    |     0.04|FALSE    | #> |OATP1B3     |     35.00|study 006 |    0.006|      0.1|FALSE    |     0.04|FALSE    | #> |OAT1        |    271.00|          |    0.001|      0.1|FALSE    |     0.04|FALSE    | #> |OAT3        |    300.00|          |    0.001|      0.1|FALSE    |     0.04|FALSE    | #> |BSEP        |     12.80|          |    0.013|      0.1|FALSE    |     0.02|FALSE    | #> |OCT2        |     67.00|study 006 |    0.002|      0.1|FALSE    |     0.02|FALSE    | #> |MATE1       |      3.60|study 006 |    0.046|      0.1|FALSE    |     0.02|TRUE     | #> |MATE2k      |      1.10|study 006 |    0.150|      0.1|TRUE     |     0.02|TRUE     |"},{"path":"/reference/transporter_reference_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Drug transporter reference data — transporter_reference_data","title":"Drug transporter reference data — transporter_reference_data","text":"Drug transporter reference data","code":""},{"path":"/reference/transporter_reference_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Drug transporter reference data — transporter_reference_data","text":"","code":"transporter_reference_data"},{"path":"/reference/transporter_reference_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Drug transporter reference data — transporter_reference_data","text":"object class data.frame 13 rows 5 columns.","code":""},{"path":"/reference/transporter_reference_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Drug transporter reference data — transporter_reference_data","text":"FDA EMA guidelines.","code":""}]
